Mannkind Corp (NASDAQ: MNKD) has seen a decline in its stock price by -1.44 in relation to its previous close of 6.26. However, the company has experienced a -4.04% decline in its stock price over the last five trading sessions. globenewswire.com reported 2025-01-06 that DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focusing on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that Dominic Marasco, RPh, has joined the company as President, Endocrine Business Unit, effective January 6, 2025.
Is It Worth Investing in Mannkind Corp (NASDAQ: MNKD) Right Now?
Mannkind Corp (NASDAQ: MNKD) has a price-to-earnings ratio of 87.77x that is above its average ratio. Additionally, the 36-month beta value for MNKD is 1.30. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for MNKD is 267.28M and currently, short sellers hold a 15.47% ratio of that float. The average trading volume of MNKD on January 10, 2025 was 2.69M shares.
MNKD’s Market Performance
MNKD stock saw a decrease of -4.04% in the past week, with a monthly decline of -9.26% and a quarterly a decrease of -4.49%. The volatility ratio for the week is 3.03%, and the volatility levels for the last 30 days are 4.63% for Mannkind Corp (MNKD). The simple moving average for the past 20 days is -5.06% for MNKD’s stock, with a 8.85% simple moving average for the past 200 days.
Analysts’ Opinion of MNKD
Many brokerage firms have already submitted their reports for MNKD stocks, with Wells Fargo repeating the rating for MNKD by listing it as a “Overweight.” The predicted price for MNKD in the upcoming period, according to Wells Fargo is $9 based on the research report published on December 20, 2024 of the previous year 2024.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see MNKD reach a price target of $10, previously predicting the price at $7. The rating they have provided for MNKD stocks is “Outperform” according to the report published on December 19th, 2024.
Leerink Partners gave a rating of “Outperform” to MNKD, setting the target price at $8 in the report published on September 09th of the previous year.
MNKD Trading at -8.65% from the 50-Day Moving Average
After a stumble in the market that brought MNKD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.13% of loss for the given period.
Volatility was left at 4.63%, however, over the last 30 days, the volatility rate increased by 3.03%, as shares sank -7.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.66% lower at present.
During the last 5 trading sessions, MNKD fell by -4.04%, which changed the moving average for the period of 200-days by +25.41% in comparison to the 20-day moving average, which settled at $6.50. In addition, Mannkind Corp saw -4.04% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MNKD starting from Binder Steven B., who sale 67,536 shares at the price of $6.89 back on Nov 22 ’24. After this action, Binder Steven B. now owns 1,075,026 shares of Mannkind Corp, valued at $465,323 using the latest closing price.
STEVEN B BINDER, the Director of Mannkind Corp, proposed sale 67,536 shares at $6.89 during a trade that took place back on Nov 22 ’24, which means that STEVEN B BINDER is holding shares at $465,397 based on the most recent closing price.
Stock Fundamentals for MNKD
Current profitability levels for the company are sitting at:
- 0.21 for the present operating margin
- 0.72 for the gross margin
The net margin for Mannkind Corp stands at 0.08. The total capital return value is set at 0.14.
Based on Mannkind Corp (MNKD), the company’s capital structure generated 12.65 points at debt to capital in total, while cash flow to debt ratio is standing at 0.18. The debt to equity ratio resting at -1.09. The interest coverage ratio of the stock is 1.53.
Currently, EBITDA for the company is 15.13 million with net debt to EBITDA at 2.51. When we switch over and look at the enterprise to sales, we see a ratio of 7.03. The receivables turnover for the company is 14.69for trailing twelve months and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.54.
Conclusion
In conclusion, Mannkind Corp (MNKD) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
